Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -209.05% is 105% below its 5-year average of -101.76%, near the low end of its 5-year range (-215.26%–-21.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.86% below its 12-month average of -157.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -209.05%.
RETURN ON INVESTED CAPITAL (ROIC)
-209.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-157.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-134.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-101.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.86%
CURRENT VS 3Y AVG
-55.80%
CURRENT VS 5Y AVG
-105.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.87%
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
-517.21%
vs the sector median at left
Femasys Inc.
Market Cap
$6.24M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-157.34%
3Y Avg
-134.18%
5Y Avg
-101.76%
Market Cap
$6.40M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.43M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$6.49M
Return on Invested Capital (ROIC)
-107.99%
TTM Avg
-407.39%
3Y Avg
-445.97%
5Y Avg
-342.27%
Market Cap
$5.98M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-84.28%
3Y Avg
-109.54%
5Y Avg
-250.89%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
Market Cap
$6.66M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-109.13%
3Y Avg
-72.14%
5Y Avg
-33.59%
Market Cap
$5.93M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$5.85M
Return on Invested Capital (ROIC)
-122.15%
TTM Avg
-90.24%
3Y Avg
-109.34%
5Y Avg
-347.01%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Femasys Inc. (FEMY) | $6.24M | -209.05% | -157.34% | -134.18% | -101.76% |
| Biomerica, Inc. (BMRA)vs › | $6.40M | -117.93% | -116.75% | -95.39% | -83.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | N/A | -251.59% | -2172.61% | -1769.42% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.49M | -107.99% | -407.39% | -445.97% | -342.27% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -82.84% | -84.28% | -109.54% | -250.89% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -57.11% | -311.64% | -524.77% | -524.77% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.66M | -219.15% | -109.13% | -72.14% | -33.59% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.93M | -0.32% | -32.77% | -50.72% | -41.90% |
| Lucyd, Inc (LUCY)vs › | $5.85M | -122.15% | -90.24% | -109.34% | -347.01% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.72M | -94.08% | -1223.16% | -731.00% | -532.24% |
ROIC
-209.0%
ROE
-304.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -209.05% |
| 2026-03-31 | -118.32% |
| 2025-12-31 | -102.93% |
| 2025-09-30 | -141.14% |
| 2025-06-30 | -215.26% |
| 2025-03-31 | -215.05% |
| 2024-12-31 | -191.90% |
| 2024-09-30 | -137.70% |
| 2024-06-30 | -92.49% |
| 2024-03-31 | -67.82% |
| 2023-12-31 | -58.73% |
| 2023-09-30 | -100.84% |
| 2023-06-30 | -93.06% |
| 2023-03-31 | -94.41% |
| 2022-12-31 | -74.80% |
| 2022-09-30 | -59.21% |
| 2022-06-30 | -46.84% |
| 2022-03-31 | -39.22% |
| 2021-12-31 | -30.78% |
| 2021-09-30 | -25.77% |
| 2021-06-30 | -21.65% |
| 2021-03-31 | -184.62% |
| 2020-12-31 | -129.65% |
